Johannes Sam

9PUBLICATIONS
87CO-AUTHORS
Haematological tumoursMechanobiologyTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 22, 2026
Molecular features of response and resistance to glofitamab, a T-cell engager for treatment of large B-cell lymphoma.

Stephan Schmeing, Sina Nassiri, Gabrielle Leclercq-Cohen

|Sep 16, 2025
Humanization of CD47 enables development of functional human neutrophils via postirradiation remodeling of the bone marrow.

Esen Sefik, William Philbrick, Fengrui Zhang

|Sep 02, 2025
Chronic antigen stimulation in melanoma induces T cell exhaustion and limits efficacy of T cell bispecific therapies.

Idil Hutter-Karakoc, Eleni Maria Varypataki, Aparna Neelakandhan

|Aug 01, 2025
Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.

Johannes Sam, Gabrielle Leclercq-Cohen, Samuel Gebhardt

|Jun 28, 2023
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies.

Gabrielle Leclercq-Cohen, Nathalie Steinhoff, Llucia Albertí Servera

Pageof 2